▲ Peaking
Business
Closely watched Pfizer lung cancer drug falls short in clinical trial
5sources
5articles
3velocity
+0%since first seen
2h agofirst detected
Velocity
How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →
Coverage (5)
- Pfizer's experimental drug misses main goal of lung cancer trial Reuters · 19h ago
- Pfizer Announces Topline Phase 3 Results for Sigvotatug Vedotin in Previously Treated Metastatic Non-Squamous Non-Small Cell Lung Cancer Business Wire · 19h ago
- PFE Stock Reacts To Mixed Topline Results For Seagen-Origin Cancer Drug Yahoo Finance · 19h ago
- Pfizer’s first new ADC from Seagen acquisition fails phase 3 NSCLC trial Fierce Biotech · 19h ago
- Closely watched Pfizer lung cancer drug falls short in clinical trial statnews.com · 19h ago
Related trends
▲ Peaking
Business
Trump Education Department to shift 7.5M off unlawful Biden student loan repayment plan
▲ Peaking
Business
75% More Pedestrians Have Been Killed Since 2009. Giant Trucks and SUVs Are Why
▲ Peaking
Business
Factory job cuts in June neared financial crisis and Covid levels, S&P says
5 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
▲ Peaking
Business
Bath & Body Works expands beyond malls with Ulta Beauty partnership, revives fan-favorite scent
5 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
▲ Peaking
Business
Trump may be mystery patient in odd case of 79yo getting experimental obesity drug
4 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
▲ Peaking
Business